Blog articles
New liquid biopsy can detect eight common cancers
Blood test could ‘change the way we screen for cancer’, though more research is needed to ensure its efficacy in a real-world screening context
Cancer immunotherapy: predicting outcomes
Today's monoclonal antibody treatments benefit some patients but can be harmful to others; the search for reliable predictive biomarkers is on
New precision medicine approaches to breast cancer
Patients in London and Manchester the first to benefit from methods to better predict, prevent and treat breast cancer, with aims to roll out nationally
Up close and personal for better breast cancer treatments
New project launched at Cancer Research Cambridge Institute helps to bring medicine based on DNA sequencing to the clinic
Liquid biopsy – a new era in personalised medicine?
Examining the promises and challenges of exciting advances taking place in genetic testing, aiming to improve diagnosis and reduce patient risk
Examining liquid biopsy in cancer management
Less-invasive method touted as potentially revolutionary for cancer care – could this mean the end for tissue biopsies?
4.50 from Paddington to Genomics
A look at the journey from arsenic and ancient alchemy to modern-day pharmacogenomics
Spot the difference: genomic sub-types of leukaemia
Recent genetic analysis exposes differences in blood cancer, offering hope for patients and the future of personalised medicine
A new genomic map of breast cancer
Latest discovery in breast cancer marks a further step towards clearer genetic understanding of the disease
Probing pancreatic cancer genomes
New genomic research offers insight into pancreatic cancer and a possible treatment revolution
Genomics and the 'healthy smoker'
While smoking is undoubtedly associated with disease, there are smokers who escape. Are they just lucky?
Progress for personalised cancer therapies
Thanks to a wave of research projects, genomics is beginning to unravel the complexities of cancer and guide treatment for patients